为什么很少有医疗保险受益人改变他们的D部分处方药计划? 来自行为科学的见解
Nathan Hodson1, Wändi Bruine de Bruin2
1University of Southern California, Los Angeles, USA. nhodson@usc.edu.
Journal of public health policy
|December 23, 2025
概括
医疗保险D部分旨在通过竞争获得更好的价值,但受益人经常在计划选择方面扎. 行为洞察力揭示了诸如复杂性和复杂性等障碍.
科学领域:
- 卫生经济学 卫生经济学
- 公共卫生政策 公共卫生政策
- 行为经济学是一种行为经济学.
背景情况:
- 医疗保险D部分为美国公共医疗保险引入了市场竞争.
- 人们对受益人应对复杂的D部分计划的能力存在担忧.
- 了解受益者选择是评估D部分价值和确定支持需求的关键.
研究的目的:
- 分析医疗保险D部分受益人如何在计划之间进行选择.
- 评估医疗保险D部分在为受益人提供价值方面取得的成功.
- 识别阻碍受益人优化其计划选择的障碍.
主要方法:
- 对Medicare Part D受益人选择的经验文献的分析.
- 检查影响计划选择的行为经济因素.
- 审查关于价格敏感性和药物坚持的现有研究.
主要成果:
- 受益人对价格和药房选择敏感,影响药物服药.
- 尽管价格敏感,但许多受益人为他们的D部分计划支付了太多的费用.
- 信息过载,信任不足和实际的"泥"阻碍了最佳的计划选择和切换.
结论:
- 行为因素显著阻碍受益人从医疗保险D部分获得最大价值的能力.
- 建议的解决方案利用行为洞察力来解决导航和选择障碍.
- 需要进行干预,以帮助受益者克服"泥"并做出明智的选择,以获得更好的健康结果.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
15.0K
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.9K
相关概念视频
Drug Dosing: Geriatric Patients
206
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
206
Drug Dosing: Obese Patients
195
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
195
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
205
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
205
Dosage Regimen: Individualization
151
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
151
The Placebo Effect
6.8K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.8K
Pharmacodynamics in Geriatric Patients: Effects of Age
174
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
174
